Application of surface-enhanced laser desorption/ionization time-of-flight-based serum proteomic array technique for the early diagnosis of prostate cancer

被引:21
作者
Pan, YZ
Xiao, XY
Zhao, D
Zhang, L
Ji, GY
Li, Y
Yang, BX
He, DC
Zhao, XJ
机构
[1] Jilin Univ, Sch Basic Med, Dept Reprod Pathophysiol, Res Ctr Prostate Dis, Changchun 130021, Peoples R China
[2] Beijing Normal Univ, Res Inst Proteom, Acad Life Sci, Res Inst Cytobiol, Beijing 100875, Peoples R China
关键词
prostate cancer; early diagnosis; protein chip; biomarker; serum;
D O I
10.1111/j.1745-7262.2006.00103.x
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
Aim: To identify the serum biomarkers of prostate cancer (PCa) by protein chip and bioinformatics. Methods: Serum samples from 83 PCa patients and 95 healthy men were taken from a mass screening in Changchun, China. Protein profiling was carried out using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS). The data of spectra were analyzed using two bioinformatics tools. Results: Eighteen serum differential proteins were identified in the PCa group compared with the control group (P < 0.01). There were four proteins at the higher serum level and 14 proteins at the lower serum level in the PCa group. A decision tree classification algorithm that used an eight-protein mass pattern was developed to correctly classify the samples. A sensitivity of 92.0% and a specificity of 96.7% for the study group were obtained by comparing the PCa and control groups. Conclusion: We identified new serum biomarkers of PCa. SELDI-TOF MS coupled with a decision tree classification algorithm will provide a highly accurate and innovative approach for the early diagnosis of PCa.
引用
收藏
页码:45 / 51
页数:7
相关论文
共 17 条
  • [1] Adam BL, 2002, CANCER RES, V62, P3609
  • [2] Gu FL, 2003, CHINESE MED J-PEKING, V116, P1391
  • [3] GU FL, 2003, CHIN MED J, V116, P1643
  • [4] Cancer statistics, 2003
    Jemal, A
    Murray, T
    Samuels, A
    Ghafoor, A
    Ward, E
    Thun, MJ
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2003, 53 (01) : 5 - 26
  • [5] Mass screening for prostate cancer: A comparative study in Natori, Japan and Changchun, China
    Kuwahara, M
    Tochigi, T
    Kawamura, S
    Ogata, Y
    Xu, N
    Wang, HL
    Zhang, HF
    Li, SW
    Li, XM
    Zhao, XJ
    [J]. UROLOGY, 2003, 61 (01) : 137 - 141
  • [6] Measurement of serum zinc improves prostate cancer detection efficiency in patients with PSA levels between 4 ng/mL and 10 ng/mL
    Li, XM
    Zhang, L
    Li, J
    Li, Y
    Wang, HL
    Ji, GY
    Kuwahara, M
    Zhao, XJ
    [J]. ASIAN JOURNAL OF ANDROLOGY, 2005, 7 (03) : 323 - 328
  • [7] Clinical proteomics: applications for prostate cancer biomarker discovery and detection
    Petricoin, EF
    Ornstein, DK
    Liotta, LA
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2004, 22 (04) : 322 - 328
  • [8] Petricoin EF, 2002, J NATL CANCER I, V94, P1576
  • [9] Use of proteomic patterns in serum to identify ovarian cancer
    Petricoin, EF
    Ardekani, AM
    Hitt, BA
    Levine, PJ
    Fusaro, VA
    Steinberg, SM
    Mills, GB
    Simone, C
    Fishman, DA
    Kohn, EC
    Liotta, LA
    [J]. LANCET, 2002, 359 (9306) : 572 - 577
  • [10] Qu YS, 2002, CLIN CHEM, V48, P1835